Document:

Exhibit 4.2

 

Astoria Financial Corporation

 

THIS NOTE IS A GLOBAL
NOTE WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF CEDE & CO AS NOMINEE OF THE
DEPOSITORY TRUST COMPANY (“DTC”) OR A NOMINEE OF DTC.  THIS NOTE IS EXCHANGEABLE FOR NOTES REGISTERED IN
THE NAME OF A PERSON OTHER THAN DTC OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND NO TRANSFER
OF THIS NOTE (OTHER THAN A TRANSFER OF THIS NOTE AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER
NOMINEE OF DTC) MAY BE REGISTERED EXCEPT IN LIMITED CIRCUMSTANCES SPECIFIED IN THE INDENTURE.

 

UNLESS THIS NOTE IS PRESENTED
BY AN AUTHORIZED REPRESENTATIVE OF DTC TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE, OR PAYMENT, AND ANY
NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF
DTC (AND ANY PAYMENT HEREON IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF
DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED
OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.

 

TRANSFERS OF THIS NOTE
SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE
AND TRANSFERS OF PORTIONS OF THIS NOTE SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE
INDENTURE REFERRED TO ON THE REVERSE HEREOF.

 

ANY PURCHASER OR HOLDER
OF THE NOTES OR ANY INTEREST THEREIN WILL BE DEEMED TO HAVE REPRESENTED AND WARRANTED BY ITS PURCHASE AND HOLDING THEREOF THAT
EITHER (I) IT IS NOT AN EMPLOYEE BENEFIT PLAN SUBJECT TO SECTION 406 OF THE U.S. EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974,
AS AMENDED (“ERISA”), A PLAN, ACCOUNT OR OTHER ARRANGEMENT SUBJECT TO SECTION 4975 OF THE U.S. INTERNAL REVENUE
CODE OF 1986, AS AMENDED (THE “CODE”), OR PROVISIONS UNDER ANY FEDERAL, STATE, LOCAL, NON-U.S. OR OTHER LAWS
OR REGULATIONS THAT ARE SIMILAR TO SUCH PROVISIONS OF ERISA OR THE CODE (COLLECTIVELY, “SIMILAR LAWS”), OR AN
ENTITY WHOSE UNDERLYING ASSETS ARE CONSIDERED TO INCLUDE “PLAN ASSETS” OF ANY SUCH PLAN, ACCOUNT OR ARRANGEMENT, AND
THAT NO PORTION OF THE ASSETS USED BY IT TO ACQUIRE AND HOLD THE NOTES CONSTITUTES ASSETS OF ANY SUCH PLAN, ACCOUNT, ARRANGEMENT
OR ENTITY FOR PURPOSES OF ERISA, THE CODE OR SIMILAR LAWS, AS APPLICABLE, OR (II) THE PURCHASE AND HOLDING OF THE NOTES WILL NOT
CONSTITUTE A NON-EXEMPT PROHIBITED TRANSACTION UNDER SECTION 406 OF ERISA OR SECTION 4975 OF THE CODE OR A VIOLATION UNDER ANY
APPLICABLE SIMILAR LAW.

 

    	 

    	 

    

 

THE NOTES DO NOT EVIDENCE
SAVINGS ACCOUNTS OR DEPOSITS AND ARE NOT INSURED BY THE FEDERAL DEPOSIT INSURANCE CORPORATION OR ANY OTHER GOVERNMENTAL AGENCY.

 

CUSIP 046265 AF1

 

5.000% Senior Notes due 2017

 

	No. 1	$250,000,000

 

Astoria Financial Corporation

 

promises to pay to Cede & Co. or registered
assigns, the principal sum of two hundred and fifty million dollars, as such sum may be increased or reduced as reflected on the
records of the Trustee in accordance with Section 2.1(b) of the within-mentioned Indenture, on June 19, 2017.

 

Interest Payment Dates:  June
19 and December 19

 

Record Dates:  June 1 and December
1

 

	 	Astoria Financial Corporation
	 	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

 

    	 

    	 

    

 

This represents Notes of Astoria Financial
Corporation

referred to in the within-mentioned Indenture:

 

WILMINGTON TRUST, NATIONAL ASSOCIATION,

as Trustee

 

	By:	 	 	Dated:
	 	Name:	 	 
	 	Title:	 	 

 

    	 

    	 

    

 

(Reverse of Note)

 

5.000% Senior Notes due 2017

 

Capitalized terms used
herein shall have the meanings assigned to them in the Indenture referred to below unless otherwise indicated.

 

1.          Interest.  Astoria
Financial Corporation (the “Company”), a Delaware corporation, promises to pay interest on the Principal Amount of
this Note at 5.000 % per annum from June 19, 2012 until maturity.  The Company shall pay interest semi-annually on June
19 and December 19 of each year, or if any such day is not a Business Day, on the next succeeding Business Day each, an “Interest
Payment Date”).  Interest on the Notes will accrue from the most recent date to which interest has been paid or,
if no interest has been paid, from the date of issuance; provided, that if there is no existing Default in the payment of
interest, and if this Note is authenticated between a record date referred to on the face hereof and the next succeeding Interest
Payment Date, interest shall accrue from such next succeeding Interest Payment Date; provided, further, that the
first Interest Payment Date shall be December 19, 2012.  Interest will be computed on the basis of a 360-day year of
twelve 30-day months and interest for any partial period shall be computed on the basis of a 360-day year of twelve 30-day months
and the number of days elapsed in any partial month.

 

2.          Method
of Payment.  The Company will pay interest on the Notes to the Persons who are registered Holders of Notes at the
close of business on the June 1st or December 1st next preceding the Interest Payment Date, even if such Notes are canceled after
such record date and on or before such Interest Payment Date, except as provided in Section 2.15 of the Indenture (as herein defined)
with respect to defaulted interest.  The Notes will be payable as to principal, premium, if any, and interest at the
office or agency of the Paying Agent (which may be the Company), or, at the option of the Company, payment of interest may be made
by check mailed to the Holders at their addresses set forth in the register of Holders, and provided that all payments of principal,
premium, if any, and interest with respect to Notes a Holder of which owns at least $50 million aggregate Principal Amount of Notes
and has given wire transfer instructions to the Company at least ten Business Days prior to the applicable payment date, will be
required to be made by wire transfer of immediately available funds to the accounts specified by the Holder thereof.  Such
payment shall be in such coin or currency of the United States of America as at the time of payment is legal tender for payment
of public and private debts.

 

3.          Paying
Agent and Registrar.  Initially, Wilmington Trust, National Association, the Trustee (“Trustee”) under
the Indenture, will act as Paying Agent and Registrar.  The Company may change any Paying Agent or Registrar without
notice to any Holder.  The Company or any of its Subsidiaries may act in any such capacity.

 

4.          Indenture.  The
Company issued this Note under an Indenture dated as of June 19, 2012, as amended or supplemented from time to time (“Indenture”),
between the Company and the Trustee.  The terms of the Notes include those stated in the Indenture and those made part
of the Indenture by reference to the TIA.  The Notes are subject to all such terms, and Holders are referred to the Indenture
and the TIA for a statement of such terms.  To the extent any provision of this Note conflicts with the express provisions
of the Indenture, the provisions of the Indenture shall govern and be controlling.

 

    	 

    	 

    

 

The Notes are unsecured
obligations of the Company.

 

5.          Optional
Redemption.  The Notes may be redeemed at any time on or after the date that is 30 days prior to the maturity date
at the option of the Company, in whole or in part, upon not less than 30 nor more than 60 days’ notice, at a price equal
to 100% of the Principal Amount of the Notes to be redeemed plus accrued and unpaid interest on the Principal Amount of the Notes
being redeemed to the Redemption Date.

 

In addition to the Company’s
right to redeem the Notes as set forth in Section 3.7 of the Indenture, the Company may at any time and from time to time purchase
Notes in open market transactions, tender offers or otherwise.

 

6.          Notice
of Redemption.  Notice of redemption will be mailed, by first class mail, at least 30 days but not more than 60 days
before the Redemption Date to each Holder whose Notes are to be redeemed at its registered address; provided that redemption notices
may be mailed more than 60 days prior to a Redemption Date if the notice is issued in connection with a defeasance of the Notes
or a satisfaction and discharge of the Indenture.  Notes in denominations larger than $2,000 may be redeemed in part
but only in whole multiples of $1,000, unless all of the Notes held by a Holder are to be redeemed.  Notes to be redeemed
shall, on the Redemption Date, become due and payable at the redemption price, and from and after such date (unless the Company
shall default in the payment of the redemption price) such Notes shall cease to bear interest.  The Company shall deposit
with the Trustee or with the Paying Agent, one Business Day prior the Redemption Date, money sufficient to pay the redemption price
on all Notes to be redeemed on that date.

 

7.          Denominations,
Transfer, Exchange.  The Notes are in registered form without coupons in denominations of $2,000 and integral multiples
of $1,000 in excess thereof.  The transfer of Notes may be registered and Notes may be exchanged as provided in the Indenture.  The
Registrar and the Trustee may require a Holder, among other things, to furnish appropriate endorsements and transfer documents
and the Company may require a Holder to pay any taxes and fees required by law or permitted by the Indenture.  The Company
and the Registrar need not exchange or register the transfer of any Note selected for redemption, in whole or in part, except for
the unredeemed portion of any Note being redeemed in part.  The Company need not exchange or register the transfer of
any Notes for a period of 15 days before a selection of Notes to be redeemed or during the period between a record date and the
next succeeding Interest Payment Date.

 

8.          Persons
Deemed Owners.  The registered Holder of a Note may be treated as its owner for all purposes.

 

    	 

    	 

    

 

9.          Amendment,
Supplement and Waiver.  Subject to certain exceptions, the Indenture or the Notes may be amended or supplemented
with the consent of the Holders of at least a majority in Principal Amount of the then outstanding Notes voting as a single class
(including, without limitation, consents obtained in connection with a purchase of, or tender offer or exchange offer for, the
Notes), and, subject to Sections 6.4, 6.6 and 6.7 of the Indenture, any existing Default or Event of Default (other than a Default
or Event of Default in the payment of the principal of, premium, if any, on and interest on the Notes, except a payment default
resulting from an acceleration that has been rescinded).  Subject to Sections 6.4, 6.6 and 6.7 of the Indenture, compliance
with any provision of the Indenture or the Notes may be waived with the consent of the Holders of a majority in Principal Amount
of the then outstanding Notes voting as a single class.  Without the consent of any Holder of a Note, the Indenture or
the Notes may be amended or supplemented to cure any ambiguity, defect or inconsistency; to provide for uncertificated Notes in
addition to or in place of Definitive Notes or to alter the provisions of Article II of the Indenture (including the related definitions)
in a manner that does not adversely affect any Holder; to provide for the assumption of the Company’s obligations to the
Holders of the Notes by a successor to the Company pursuant to Article V of the Indenture; to confirm the text of the Indenture,
any supplemental indenture, if applicable, or the Notes to any provision set forth under the heading “Description of the
Notes” in a prospectus supplement applicable to the Notes; to supplement any of the provisions of the Indenture to such extent
as shall be necessary to permit or facilitate the defeasance and discharge of any Note pursuant to Article VIII, provided that
any such action shall not adversely affect the interests of any Holder in any material respect; to make any change that would provide
any additional rights or benefits to the Holders of the Notes; to make any change that is not inconsistent with the Indenture and
does not adversely affect the legal rights under the Indenture of any Holder of Notes; or to comply with the requirements of the
SEC in order to effect or maintain the qualification of the Indenture under the TIA.

 

10.         Defaults
and Remedies.  An “Event of Default” occurs if:  (i) the Company defaults in the payment of
any installment of interest upon any of the Notes as and when the same shall become due and payable, and such default continues
for a period of 30 days; (ii) the Company defaults in the payment of all or any part of the principal of any of the Notes as and
when the same shall become due and payable either at maturity, upon any redemption, by declaration of acceleration or otherwise;
(iii) the Company fails to perform any other covenant or agreement on the part of the Company contained in the Notes or in the
Indenture and such failure continues for a period of 90 days after the date on which notice specifying such failure, stating that
such notice is a “Notice of Default” under the Indenture and demanding that the Company remedy the same, shall have
been given to the Company by the Trustee, or to the Company and the Trustee by the Holders of at least 25% in aggregate Principal
Amount of the Notes at the time outstanding; (iv) a court having jurisdiction in the premises shall enter a decree or order for
relief in respect of the Company or the Material Subsidiary in an involuntary case or proceeding under any applicable bankruptcy,
insolvency, reorganization or other similar law now or hereafter in effect, or a decree or order adjudging the Company or the Material
Subsidiary a bankrupt or insolvent, or approving as properly filed a petition seeking reorganization, arrangement, adjustment,
or composition of or in respect of the Company or the Material Subsidiary under any applicable federal or state law, or appointing
a receiver, liquidator, assignee, custodian, trustee, sequestrator or similar official of the Company or the Material Subsidiary
or for any substantial part of its property or ordering the winding up or liquidation of its affairs, shall have been entered,
and such decree or order shall remain unstayed and in effect for a period of 60 consecutive days; (v) the Company or the Material
Subsidiary shall commence a voluntary case or proceeding under any applicable federal or state bankruptcy, insolvency, reorganization
or other similar law now or hereafter in effect or any other case or proceeding to be adjudicated a bankrupt or insolvent, or consent
to the entry of a decree or order for relief in an involuntary case or proceeding under any such law, or to the commencement of
any bankruptcy or insolvency case or proceeding against the Company or the Material Subsidiary, or the filing by the Company or
the Material Subsidiary of a petition or answer to consent seeking reorganization or relief under any such applicable federal or
state law, or the consent by the Company or the Material Subsidiary to the filing of such petition or to the appointment of or
the taking possession by a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company
or the Material Subsidiary or of any substantial part of its property, or the making by the Company or the Material Subsidiary
of an assignment for the benefit of creditors, or the taking of action by the Company or the Material Subsidiary in furtherance
of any such action; or (vi) the Company shall default under any bond, debenture, note or other evidence of indebtedness for money
borrowed by the Company or the Material Subsidiary having an aggregate principal amount outstanding of at least $50,000,000, or
under any mortgage, indenture or instrument (including this Indenture) under which there may be issued or by which there may be
secured or evidenced any indebtedness for money borrowed by the Company or the Material Subsidiary having an aggregate principal
amount outstanding of at least $50,000,000, whether such indebtedness now exists or is created or incurred in the future, which
default (a) constitutes a failure to pay any portion of the principal of such indebtedness when due and payable after the expiration
of any applicable grace period or (b) results in such indebtedness becoming due or being declared due and payable prior to the
date on which it otherwise would have become due and payable without, in the case of clause (a), such indebtedness having been
discharged or, in the case of clause (b), without such indebtedness having been discharged or such acceleration having been rescinded
or annulled.  If any Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in Principal
Amount of the then outstanding Notes may declare all the Notes to be due and payable immediately.  Holders of the Notes
may not enforce the Indenture or the Notes except as provided in the Indenture.  The Trustee may withhold from Holders
of the Notes notice of any continuing Default or Event of Default (except a Default or Event of Default relating to the payment
of principal or interest) if it determines that withholding notice is in their interest.  The Holders of a majority in
aggregate Principal Amount of the then outstanding Notes by written notice to the Trustee may on behalf of the Holders of all of
the Notes waive any existing Default or Event of Default and its consequences under the Indenture, except a continuing Default
or Event of Default in the payment of the principal of or interest on the Notes.

 

    	 

    	 

    

 

11.         Trustee
Dealings with Company.  The Trustee, in its individual or any other capacity, may become the owner or pledgee of
Notes and may otherwise deal with the Company or any Affiliate of the Company with the same rights it would have if it were not
the Trustee.

 

12.         Discharge
and Defeasance.  Subject to certain conditions, the Company at any time shall be entitled to terminate some or all
of its obligations under the Notes and the Indenture if the Company deposits with the Trustee cash in United States dollars, non-callable
Government Securities, or a combination thereof, in such amounts as will be sufficient, in the opinion of a nationally recognized
firm of independent public accountants, to pay the principal of, premium, if any, on and interest on the outstanding Notes on the
stated maturity or on the applicable Redemption Date, as the case may be.

 

13.         No
Recourse Against Others.  No recourse under or upon any obligation, covenant or agreement contained in this Indenture
or in any Note, or for any claim based thereon or otherwise in respect thereof, shall be had against any incorporator, shareholder,
employee, officer, or director, as such, past, present or future, of the Company, either directly or through the Company, whether
by virtue of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being
expressly understood that this Indenture and the obligations issued hereunder are solely obligations of the Company, and that no
such personal liability whatever shall attach to, or is or shall be incurred by, the incorporators, shareholders, employees, officers
or directors, as such, of the Company, or any of them, because of the creation of the indebtedness hereby authorized, or under
or by reason of the obligations, covenants or agreements contained in this Indenture or in any Note or implied therefrom; and that
any and all such personal liability of every name and nature, either at common law or in equity or by constitution or statute or
otherwise, of, and any and all such rights and claims against, every such incorporator, shareholder, employee, officer or director,
as such, because of the creation of the indebtedness hereby authorized, or under or by reason of the obligations, covenants or
agreements contained in this Indenture or in any Note or implied therefrom, are hereby expressly waived and released as a condition
of, and as a consideration for, the execution of this Indenture and the issuance of such Note.

 

    	 

    	 

    

 

14.         Authentication.  This
Note shall not be valid until authenticated by the manual signature of the Trustee or an authenticating agent.

 

15.         Abbreviations.  Customary
abbreviations may be used in the name of a Holder or an assignee, such as:  TEN COM (= tenants in common), TEN ENT (=
tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= custodian),
and U/G/M/A (= Uniform Gifts to Minors Act).  Additional abbreviations may also be used though not in the above list.

 

16.         CUSIP
Numbers.  Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification Procedures,
the Company has caused CUSIP numbers to be printed on the Notes and the Trustee may use CUSIP numbers in notices of redemption
as a convenience to Holders.  No representation is made as to the accuracy of such numbers either as printed on the Notes
or as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon.

 

17.         Available
Information.  The Company will furnish to any Holder upon written request and without charge a copy of the Indenture.  Requests
may be made to:

 

Astoria Financial Corporation

One Astoria Federal Plaza

Lake Success, New York  11042

Attention:  General Counsel

 

18.         Counterparts.  This
Note may be executed by one or more of the parties to this Note on any number of separate counterparts, and all of said counterparts
taken together shall be deemed to constitute one and the same instrument.

 

19.         Governing
Law.  THIS NOTE SHALL BE DEEMED TO BE A CONTRACT MADE UNDER THE LAWS OF THE STATE OF NEW YORK AND SHALL BE GOVERNED
BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAW PRINCIPLES THEREOF OTHER
THAN SECTION 5-1401 OF THE NEW YORK GENERAL OBLIGATIONS LAW.

 

    	 

    	 

    

 

Assignment Form

 

	To assign this Note, fill in the form below:  (I) or (we) assign and transfer this Note to
	 
	(Insert assignee’s Social Security or Tax Identification number)
	 
	 
	 
	 
	(Print or type assignee’s name, address and zip code)
	 
	and irrevocably appoint     	 	   to transfer this Note
	on the books of the Company.  The agent may substitute another to act for him.
	 

 

Date:______________________

 

	 	Your signature:___________________________ 

(Sign exactly as your name appears on the face of this Note)
	 	 
	 	Tax Identification No.:  __________________ 

SIGNATURE GUARANTEE:
	 	 
	 	 
	 	Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended.Exhibit 10.1

 

USE OF NAME LICENSE AGREEMENT

 

THIS USE OF NAME LICENSE
AGREEMENT (the “Agreement”) is made to be effective as of June 15, 2012 (the “Effective Date”),
by and between ERBA Diagnostics, Inc., a Delaware corporation formerly known as IVAX Diagnostics, Inc. (“Miami”),
and ERBA Diagnostics Mannheim GmbH, a company headquartered in Germany (“Mannheim”).

 

RECITALS

 

WHEREAS, on September
1, 2010, Mannheim became the majority stockholder of Miami; and

 

WHEREAS, on the Effective
Date, with the consent of Mannheim, Miami changed its name to be known as “ERBA Diagnostics, Inc.” and will use the
name “ERBA” in its name and in connection with the offering of its products and services, and Mannheim is agreeable
to allow Miami to use its name in such manner.

 

AGREEMENT

 

NOW, THEREFORE, in
consideration of the mutual promises, covenants and agreements contained herein, the parties agree as follows:

 

1.     License.
In consideration of Miami’s payment to Mannheim of $1 USD per year during the term of this Agreement (the first such payment
to be made on the Effective Date, and each subsequent payment to be made on the applicable anniversary thereof), and other good
and valuable consideration, the sufficiency and receipt of which are hereby acknowledged, Mannheim grants to Miami a fully paid,
royalty-free, non-exclusive license to use the name “ERBA” (the “Name”) and any stylized logos or
marks associated with the Name (collectively, the Name, stylized logos and marks are referred to herein as the “Licensed
Property”) in its corporate name, domain name, promotional literature and product and service descriptions and for other
general commercial purposes all in accordance with the terms and conditions set forth in this Agreement (collectively, the “License”).

 

2.     Rights
and Title to Licensed Property. Miami acknowledges that, unless and until Mannheim transfers to Miami all rights, title and
interest in and to all of the Licensed Property, as provided in Section 5, all rights, title and interest in and to the
Licensed Property shall remain with Mannheim. Unless and until such transfer occurs, other than the License granted in this Agreement,
Miami disclaims any right or interest to the Licensed Property or the goodwill derived therefrom.

 

3.     Protection
of the Name. Miami agrees that it shall use commercially reasonable efforts to protect the Licensed Property, including, without
limitation, Miami shall file a trademark application with the United States Patent and Trademark Office for the use of the Name
in the United States of America (the “Registered Trademark”). Miami agrees that it shall use the Licensed Property
only in accordance with Mannheim’s reasonable written instructions. When requested by Mannheim, Miami shall send samples
of advertising and promotional materials using, as well as goods bearing or sold under, the Licensed Property, which may permit
Mannheim to reasonably determine whether Miami’s uses of the Licensed Property meet the standards, specifications and directions
reasonably established by Mannheim. Miami agrees that it shall use commercially reasonable efforts to prevent the unauthorized
use of the Licensed Property by third parties. Miami shall promptly provide Mannheim written notice of all such unauthorized uses
about which Miami becomes aware and a written description of the actions Miami has taken or is taking to prevent such unauthorized
use. Where Mannheim in the exercise of its sole discretion deems appropriate, Mannheim will permit Miami to intervene in any litigation
brought by or against Mannheim concerning the Licensed Property. Miami agrees that it will take all commercially reasonable actions
requested by Mannheim that Mannheim, in good faith, reasonably believes are necessary for the protection of the Licensed Property.
Miami covenants that it will not knowingly take any actions that will damage or harm the Licensed Property.

 

    	 

    	 	

    
 

4.     Mannheim’s
Right to Advertise and Promote of Miami’s Products and Services. The parties hereby agree that Mannheim shall have the non-exclusive
right, and Miami hereby grants to Mannheim the non-exclusive right, at Mannheim’s option, to conduct advertising and promotional
campaigns with respect to Miami’s products and services, including, but not limited to, those containing the Licensed Property.
When requested by Miami, Mannheim shall send samples of any and all such advertising and promotional materials which may permit
Miami to reasonably determine whether they meet Miami’s standards for the advertising and promotion of the applicable products
and services. Mannheim covenants that it will not knowingly take any actions that will damage or harm the products and services
of Miami, including, but not limited to, those with respect to which it is providing advertising and promotional services. Miami
shall reimburse Mannheim for any and all reasonable costs and expenses incurred by Mannheim with respect to the advertising and
promotional services contemplated by this Section 4 promptly after an invoice therefor is received by Miami. Such invoices
shall be delivered to Miami on at least a monthly basis and shall contain such information and detail as may reasonably be necessary
to understand the costs and expenses incurred by Mannheim and the advertising and promotional services as to which they relate.

 

5.     Abandonment
of Licensed Property. If Mannheim decides that it no longer wishes to use the Licensed Property for any commercial purpose
whatsoever, and it determines to abandon the same, then Mannheim agrees that upon making such determination it shall provide written
notice of such determination immediately to Miami and, upon payment by Miami of $1 USD to Mannheim, Mannheim shall transfer all
of its rights, title and interest in and to the Licensed Property to Miami. Mannheim and Miami shall execute any and all documents
necessary to effectuate such transfer. The date that such transfer becomes effective shall be known as the “Transfer Date.”

 

6.     Term
of Agreement. This Agreement shall commence on the Effective Date and, unless earlier terminated pursuant to Section 9,
continue thereafter until the earlier of: (a) the Transfer Date; and (b) such time, if any, as Mannheim no longer owns, directly
or indirectly, shares of Miami’s common stock representing more than 50% of the issued and outstanding shares of such stock
(the “Share Threshold Date”).

 

    	2

    	 

    
 

7.     Sublicensing
and Assignment. Miami may not assign, sublicense or encumber the License or this Agreement without the express prior written
consent of Mannheim. Mannheim may assign, sublicense or encumber the License or this Agreement.

 

8.     Representations
and Warranties of Mannheim. Mannheim represents and warrants to Miami that, to its knowledge, it owns the Licensed Property
and has the right to license the Licensed Property to Miami. Mannheim further represents to Miami that, to its knowledge, its use
of the Licensed Property and the License hereunder do not infringe upon the rights of any other person and no person has made any
claim related thereto.

 

9.     Termination;
Effect of Termination. Mannheim may terminate this Agreement at any time after the first anniversary of the Effective Date
and prior to the earlier of the Transfer Date and the Share Threshold Date: (a) upon providing Miami one hundred eighty (180) days
prior written notice of its intent to terminate and the date upon which the Agreement shall terminate; or (b) upon providing Miami
thirty (30) days prior written notice of any breach of this Agreement by Miami, which breach remains uncured at the end of such
thirty (30) day period. Upon the termination of this Agreement in accordance with this Section 9 or, if applicable, the
expiration of this Agreement on the Share Threshold Date, Miami agrees that it shall take all steps as are reasonably necessary
to cause the Registered Trademark to be assigned to Mannheim. The parties acknowledge that, upon termination of this Agreement
pursuant to this Section 9 or, if applicable, the expiration of this Agreement on the Share Threshold Date, Miami will have
to amend its Certificate of Incorporation to change its name and that such action will require the affirmative vote of its stockholders.
Miami agrees that it shall take all steps as are reasonably necessary to change its name as soon as is reasonably practicable following
termination of this Agreement in accordance with this Section 9 or, if applicable, expiration of this Agreement on the Share
Threshold Date.

 

10.     Entire
Agreement; No Oral Modifications. This Agreement contains the entire agreement among the parties with respect to the subject
matter hereof and supersedes all prior agreements and understandings with respect thereto and may not be amended or modified except
in a writing signed by both of the parties.

 

11.     Binding
Effect; Benefits. This Agreement shall inure to the benefit of and be binding upon the parties and their respective heirs,
successors and permitted assigns; however, nothing in this Agreement, expressed or implied, is intended to confer on any individual
or entity other than the parties, or their respective heirs, successors or permitted assigns, any rights, remedies, obligations
or liabilities under or by reason of this Agreement.

 

12.     Counterparts.
This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which
together shall be deemed to be one and the same instrument.

 

13.     Governing
Law. This Agreement shall be governed by, and construed and enforced in accordance with, the laws of the United States of America
and the State of Florida, both substantive and remedial.

 

    	3

    	 

    
 

14.     Notices.
All notices, requests, demands and other communications called for or contemplated hereunder shall be in writing and shall be deemed
to have been duly given if personally delivered against written receipt or by facsimile transmission or mailed first class certified
mail, return receipt requested, or sent by overnight courier prepaid to the other party at the following addresses or facsimile
numbers:

 

If to Mannheim,
then to:

 

ERBA Diagnostics Mannheim GmbH

c/o Transasia Bio-medicals Ltd.

Transasia House

8 Chandivali Studio Road

Mumbai, India 400072

	Facsimile:	011 (+91) 22 2857 3030
	Attention:	Chief Executive Officer

 

If to Miami,
then to:

 

ERBA Diagnostics,
Inc.

2140 North Miami Avenue

Miami, Florida 33127

	Facsimile:	(305) 324-2395
	Attention:	Chief Executive Officer

 

15.     Headings.
The section headings herein are included for convenience only and are not to be deemed a part of this Agreement.

 

16.     Remedies.
Each of the parties to this Agreement shall be entitled to enforce its rights under this Agreement specifically, to recover damages
and costs (including, without limitation, reasonable attorneys’ fees and costs) for any breach of any provision of this Agreement
and to exercise all other rights existing in its favor. The parties agree that money damages may not be an adequate remedy for
either party in the event of a breach of the material provisions of this Agreement, and that either party may apply to any court
of law or equity of competent jurisdiction for specific performance and/or injunctive relief (without posting any bond or deposit)
in order to enforce or prevent any violations of the provisions of this Agreement. The rights and remedies given in this Agreement
to a non-breaching party shall be deemed cumulative, and the exercise of one of such remedies shall not operate to bar the exercise
of any other rights and remedies reserved to a non-breaching party under this Agreement or given to a non-breaching party at law
or in equity.

 

17.     Attorneys’
Fees. In the event of any dispute or controversy arising out of this Agreement, the prevailing party shall be entitled to recover
from the other party, and such other party shall pay on demand, all costs and expenses, including, without limitation, reasonable
attorneys’ fees and costs, incurred in connection with such dispute or controversy.

 

    	4

    	 

    
 

18.     Construction.
The language used in this Agreement shall be deemed to be the language chosen by the parties to express their mutual intent, and
no rule of strict construction shall be applied against any party.

 

 

[ SIGNATURE PAGE FOLLOWS ]

 

    	5

    	 

    
 

IN WITNESS WHEREOF,
each party has duly executed this Agreement to be effective as of the Effective Date.

 

	 	ERBA Diagnostics, Inc.,
	 	a Delaware corporation formerly known as
	 	IVAX Diagnostics, Inc.
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	By:	/s/ Kevin D. Clark	 
	 	 	Kevin D. Clark,	 
	 	 	Chief Executive Officer,	 
	 	 	Chief Operating Officer and President	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	ERBA Diagnostics Mannheim GmbH,
	 	a company headquartered in Germany
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	By:	/s/ Suresh Vazirani	 
	 	 	Suresh Vazirani,	 
	 	 	Chief Executive Officer and	 
	 	 	Managing Director	 
	 	 	 	 

 

    	6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00205-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00205-of-00352.parquet"}]]